RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Isotope & Radiation Stock

China Isotope & Radiation Net Income 2024

China Isotope & Radiation Net Income

126.69 M CNY

Ticker

1763.HK

ISIN

CNE1000031F4

In 2024, China Isotope & Radiation's profit amounted to 126.69 M CNY, a -65.85% increase from the 370.97 M CNY profit recorded in the previous year.

The China Isotope & Radiation Net Income history

YEARNET INCOME (undefined CNY)
2025e192.54
2024e126.69
2023370.97
2022392.28
2021335.75
2020213.58
2019329.03
2018321.9
2017271.45
2016262.11
2015254.21

China Isotope & Radiation Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into China Isotope & Radiation, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by China Isotope & Radiation from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects China Isotope & Radiation’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of China Isotope & Radiation. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into China Isotope & Radiation’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing China Isotope & Radiation’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on China Isotope & Radiation’s growth potential.

China Isotope & Radiation Revenue, EBIT and net profit per share

DateChina Isotope & Radiation RevenueChina Isotope & Radiation EBITChina Isotope & Radiation Net Income
2025e9.13 B undefined1.62 B undefined192.54 M undefined
2024e7.66 B undefined1.17 B undefined126.69 M undefined
20236.63 B undefined724.79 M undefined370.97 M undefined
20226.15 B undefined836.61 M undefined392.28 M undefined
20215.14 B undefined744.61 M undefined335.75 M undefined
20204.27 B undefined582.33 M undefined213.58 M undefined
20193.99 B undefined671.53 M undefined329.03 M undefined
20183.25 B undefined618.06 M undefined321.9 M undefined
20172.67 B undefined513.66 M undefined271.45 M undefined
20162.36 B undefined488.12 M undefined262.11 M undefined
20152.15 B undefined453.45 M undefined254.21 M undefined

China Isotope & Radiation stock margins

The China Isotope & Radiation margin analysis displays the gross margin, EBIT margin, as well as the profit margin of China Isotope & Radiation. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for China Isotope & Radiation.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the China Isotope & Radiation's sales revenue. A higher gross margin percentage indicates that the China Isotope & Radiation retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the China Isotope & Radiation's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the China Isotope & Radiation's total revenue generated. When comparing the revenue margin year over year, investors can gauge the China Isotope & Radiation's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the China Isotope & Radiation. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the China Isotope & Radiation's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

China Isotope & Radiation Margin History

China Isotope & Radiation Gross marginChina Isotope & Radiation Profit marginChina Isotope & Radiation EBIT marginChina Isotope & Radiation Profit margin
2025e52.48 %17.78 %2.11 %
2024e52.48 %15.24 %1.65 %
202352.48 %10.92 %5.59 %
202257.17 %13.6 %6.37 %
202163.03 %14.48 %6.53 %
202061.2 %13.62 %5 %
201970.93 %16.83 %8.25 %
201870.8 %19.02 %9.91 %
201770.54 %19.22 %10.16 %
201670.43 %20.66 %11.09 %
201569.1 %21.07 %11.81 %

China Isotope & Radiation Aktienanalyse

What does China Isotope & Radiation do?

China Isotope & Radiation Corp (CIRC) is a Chinese company specialized in the production and sale of nuclear products and services. It was founded in 1990 and is headquartered in Beijing. CIRC's history dates back to the 1950s when China conducted atomic experiments. In the 1960s, the country began producing radioisotopes for use in medicine, industry, and agriculture. CIRC was later established as a company to organize the production and sale of these products and services. CIRC's business model is based on the production and sale of radioisotopes and their applications in various fields such as medicine, industry, environmental monitoring, and research. The company aims to provide high-quality products and services to meet its customers' needs. CIRC has different divisions focusing on the various applications of radioisotopes. One important division is the medical application, which focuses on the production of radioisotopes for cancer diagnosis and therapy, cardiovascular diseases, and other illnesses. The company also produces radioactive drugs that can be used in the diagnosis and treatment of various diseases. Another important division of CIRC is the industrial application of radioisotopes, which focuses on the measurement of thickness, density, and radiation in various products and materials. The company also offers services in surface treatment and material testing. CIRC is also involved in environmental monitoring, offering products and services for the measurement and monitoring of air, water, and soil pollution. The company is also engaged in research and development, developing new products and applications of radioisotopes. CIRC offers a wide range of products, including various types of radioisotopes, radioactive drugs, radiation measurement devices and systems, as well as instruments and equipment for radioisotope production. CIRC is a leading provider of radioisotopes and related services in China and has a strong presence in other countries as well. The company has established itself as a reliable partner for customers in various industries and is committed to the highest quality and customer satisfaction. China Isotope & Radiation ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding China Isotope & Radiation's Profit Margins

The profit margins of China Isotope & Radiation represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of China Isotope & Radiation's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating China Isotope & Radiation's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

China Isotope & Radiation's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When China Isotope & Radiation’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about China Isotope & Radiation stock

How much profit has China Isotope & Radiation made this year?

China Isotope & Radiation has made 126.69 M CNY this year.

How has the profit developed compared to last year?

The profit has increased by -65.85% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does China Isotope & Radiation publish its earnings?

China Isotope & Radiation publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of China Isotope & Radiation?

The profits of China Isotope & Radiation are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of China Isotope & Radiation?

You can learn more about the earnings of China Isotope & Radiation by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does China Isotope & Radiation pay?

Over the past 12 months, China Isotope & Radiation paid a dividend of 0.48 CNY . This corresponds to a dividend yield of about 5.55 %. For the coming 12 months, China Isotope & Radiation is expected to pay a dividend of 0.51 CNY.

What is the dividend yield of China Isotope & Radiation?

The current dividend yield of China Isotope & Radiation is 5.55 %.

When does China Isotope & Radiation pay dividends?

China Isotope & Radiation pays a quarterly dividend. This is distributed in the months of August, July, July, October.

How secure is the dividend of China Isotope & Radiation?

China Isotope & Radiation paid dividends every year for the past 8 years.

What is the dividend of China Isotope & Radiation?

For the upcoming 12 months, dividends amounting to 0.51 CNY are expected. This corresponds to a dividend yield of 5.89 %.

In which sector is China Isotope & Radiation located?

China Isotope & Radiation is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Isotope & Radiation kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Isotope & Radiation from 11/22/2024 amounting to 0.072 CNY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did China Isotope & Radiation pay the last dividend?

The last dividend was paid out on 11/22/2024.

What was the dividend of China Isotope & Radiation in the year 2023?

In the year 2023, China Isotope & Radiation distributed 0.44 CNY as dividends.

In which currency does China Isotope & Radiation pay out the dividend?

The dividends of China Isotope & Radiation are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Isotope & Radiation

Our stock analysis for China Isotope & Radiation Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Isotope & Radiation Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.